BIO-RAD LABORATORIES-A (BIO) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:BIO - US0905722072 - Common Stock
BIO Key Statistics, Chart & Performance
The current stock price of BIO is 302.99 USD. In the past month the price decreased by -4.89%. In the past year, price decreased by -8.39%.
BIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.87 | 217.71B | ||
| DHR | DANAHER CORP | 29.69 | 161.70B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 183 | 55.61B | ||
| A | AGILENT TECHNOLOGIES INC | 24.39 | 38.58B | ||
| IQV | IQVIA HOLDINGS INC | 19.38 | 38.39B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.32 | 28.48B | ||
| WAT | WATERS CORP | 29.91 | 22.61B | ||
| ILMN | ILLUMINA INC | 30.08 | 20.04B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.92 | 19.79B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.28 | 15.82B | ||
| RVTY | REVVITY INC | 20.2 | 10.97B | ||
| TEM | TEMPUS AI INC | N/A | 10.51B |
Related stock screener links
About BIO
Company Profile
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,700 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Company Info
BIO-RAD LABORATORIES-A
1000 Alfred Nobel Dr
Hercules CALIFORNIA 94547 US
CEO: Norman Schwartz
Employees: 7700
Phone: 15107247000
BIO-RAD LABORATORIES-A / BIO FAQ
What does BIO do?
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,700 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Can you provide the latest stock price for BIO-RAD LABORATORIES-A?
The current stock price of BIO is 302.99 USD. The price decreased by -0.5% in the last trading session.
Does BIO stock pay dividends?
BIO does not pay a dividend.
How is the ChartMill rating for BIO-RAD LABORATORIES-A?
BIO has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists BIO stock?
BIO stock is listed on the New York Stock Exchange exchange.
Can you provide the PE ratio for BIO stock?
The PE ratio for BIO-RAD LABORATORIES-A (BIO) is 29.39. This is based on the reported non-GAAP earnings per share of 10.31 and the current share price of 302.99 USD.
Can you provide the upcoming earnings date for BIO-RAD LABORATORIES-A?
BIO-RAD LABORATORIES-A (BIO) will report earnings on 2026-02-11, after the market close.
BIO Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to BIO. When comparing the yearly performance of all stocks, BIO is a bad performer in the overall market: 68.08% of all stocks are doing better.
BIO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BIO. BIO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
BIO Financial Highlights
Over the last trailing twelve months BIO reported a non-GAAP Earnings per Share(EPS) of 10.31. The EPS decreased by -1.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.97% | ||
| ROE | -10.03% | ||
| Debt/Equity | 0.18 |
BIO Forecast & Estimates
10 analysts have analysed BIO and the average price target is 362.1 USD. This implies a price increase of 19.51% is expected in the next year compared to the current price of 302.99.
For the next year, analysts expect an EPS growth of -2.19% and a revenue growth 0.15% for BIO